Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Macron Visits Novo Nordisk Pharmaceutical Company - Chartres

President Emmanuel Macron, alongside Novo Nordisk CEO Lars Fruergaard Jorgensen, visits the Danish multinational pharmaceutical company Novo Nordisk in Chartres, central France, on November 23, 2023. Emmanuel Macron will formalise on November 23, 2023 in Chartres (Eure-et-Loir) an investment of more than two billion euros from the Danish Novo Nordisk in the production of drugs for diabetes and obesity, thus adding a new aspect to the reindustrialisation of the country. Photo by Stephane Lemouton/Pool/ABACAPRESS.COM

E

Macron Visits Novo Nordisk Pharmaceutical Company - Chartres

President Emmanuel Macron visits the Danish multinational pharmaceutical company Novo Nordisk in Chartres, central France, on November 23, 2023. Emmanuel Macron will formalise on November 23, 2023 in Chartres (Eure-et-Loir) an investment of more than two billion euros from the Danish Novo Nordisk in the production of drugs for diabetes and obesity, thus adding a new aspect to the reindustrialisation of the country. Photo by Stephane Lemouton/Pool/ABACAPRESS.COM

E

Macron Visits Novo Nordisk Pharmaceutical Company - Chartres

President Emmanuel Macron visits the Danish multinational pharmaceutical company Novo Nordisk in Chartres, central France, on November 23, 2023. Emmanuel Macron will formalise on November 23, 2023 in Chartres (Eure-et-Loir) an investment of more than two billion euros from the Danish Novo Nordisk in the production of drugs for diabetes and obesity, thus adding a new aspect to the reindustrialisation of the country. Photo by Stephane Lemouton/Pool/ABACAPRESS.COM

E

Macron Visits Novo Nordisk Pharmaceutical Company - Chartres

President Emmanuel Macron visits the Danish multinational pharmaceutical company Novo Nordisk in Chartres, central France, on November 23, 2023. Emmanuel Macron will formalise on November 23, 2023 in Chartres (Eure-et-Loir) an investment of more than two billion euros from the Danish Novo Nordisk in the production of drugs for diabetes and obesity, thus adding a new aspect to the reindustrialisation of the country. Photo by Stephane Lemouton/Pool/ABACAPRESS.COM

E

Macron Visits Novo Nordisk Pharmaceutical Company - Chartres

President Emmanuel Macron visits the Danish multinational pharmaceutical company Novo Nordisk in Chartres, central France, on November 23, 2023. Emmanuel Macron will formalise on November 23, 2023 in Chartres (Eure-et-Loir) an investment of more than two billion euros from the Danish Novo Nordisk in the production of drugs for diabetes and obesity, thus adding a new aspect to the reindustrialisation of the country. Photo by Stephane Lemouton/Pool/ABACAPRESS.COM

E

Macron Visits Novo Nordisk Pharmaceutical Company - Chartres

President Emmanuel Macron visits the Danish multinational pharmaceutical company Novo Nordisk in Chartres, central France, on November 23, 2023. Emmanuel Macron will formalise on November 23, 2023 in Chartres (Eure-et-Loir) an investment of more than two billion euros from the Danish Novo Nordisk in the production of drugs for diabetes and obesity, thus adding a new aspect to the reindustrialisation of the country. Photo by Stephane Lemouton/Pool/ABACAPRESS.COM

E

Macron Visits Novo Nordisk Pharmaceutical Company - Chartres

President Emmanuel Macron, alongside Novo Nordisk CEO Lars Fruergaard Jorgensen, visits the Danish multinational pharmaceutical company Novo Nordisk in Chartres, central France, on November 23, 2023. Emmanuel Macron will formalise on November 23, 2023 in Chartres (Eure-et-Loir) an investment of more than two billion euros from the Danish Novo Nordisk in the production of drugs for diabetes and obesity, thus adding a new aspect to the reindustrialisation of the country. Photo by Stephane Lemouton/Pool/ABACAPRESS.COM

E

Macron Visits Novo Nordisk Pharmaceutical Company - Chartres

President Emmanuel Macron visits the Danish multinational pharmaceutical company Novo Nordisk in Chartres, central France, on November 23, 2023. Emmanuel Macron will formalise on November 23, 2023 in Chartres (Eure-et-Loir) an investment of more than two billion euros from the Danish Novo Nordisk in the production of drugs for diabetes and obesity, thus adding a new aspect to the reindustrialisation of the country. Photo by Stephane Lemouton/Pool/ABACAPRESS.COM